Proud to be part of the EUCAIM project!


January 23, 2023
Open Call EUCAIM

EUropean Federation for CAncer IMages (EUCAIM) is the cornerstone of the European Commission-initiated European Cancer Imaging Initiative, a flagship of the Europe’s Beating Cancer Plan (EBCP), which aims to foster innovation and deployment of digital technologies in cancer treatment and care to achieve more precise and faster clinical decision making, diagnostics, treatment and predictive medicine for cancer patients. The project involves 76 organisations and is coordinated by the European Institute for Biomedical Imaging Research (EIBIR). The project kicked off in Brussels this week.

Read the press release from EIBIR.

Artificial Intelligence is a powerful tool that can support cancer detection, diagnosis and treatment. The development of innovative digital solutions relies on data, including cancer imaging data. The objective of the European Cancer Imaging Initiative is to deploy a federated infrastructure of cancer images covering different cancer types, making them available to clinicians, researchers and innovators. It will allow for the development, benchmarking, testing and piloting of Artificial Intelligence-based technologies for cancer diagnosis and treatment.

Within the European Cancer Imaging Initiative, the EUCAIM project supports this objective. Euro-BioImaging is proud to participate in the project alongside several Med Nodes, DIMP Neuromed and Portuguese Brain Imaging Network Node (University of Coimbra), as well as the Population Imaging Flagship Node Rotterdam (ERASMUS MC) and IRCSS SDN, part of the MMMI Italian Node.

Euro-BioImaging and its Nodes will contribute to a number of Work Packages to help build the backbone for the next generation of cancer diagnostics and treatments. Our work will focus on building the Data Federation & Interoperability Framework (WP5) as well as contributing Use cases for platform expansion and validation (WP7). We are working together with MATICAL (co-lead WP8) on Business & Sustainability models to establish legal, financial and operational structure to sustain the Central Hub in the long-term.

The project also links to the data expertise and engagement of Euro-BioImaging and its Nodes and also links closely to several projects we are participating in, including EOSC4Cancer, CanSERV, and AI4Life.

We very much look forward to working on this project with 76 other organizations from 20 countries, including hospitals, universities, industries, and other research infrastructures.

More information coming soon: www.cancerimage.eu

Some of these texts were reused based on the European Cancer Imaging Factsheet (PDF) provided by the EU Commission. For the full text, please view the Factsheet available for download on this page: https://digital-strategy.ec.europa.eu/en/policies/cancer-imaging


More news from Euro-BioImaging

ISCaM/Virtual Pub

November 4, 2024

Emerging Tools for the Improved In Vivo Metabolic MRI Characterization of Cancer

On November 8, 2024, Euro-BioImaging hosts the Cancer Metabolism Series in collaboration with the International Society of Cancer Metabolism (ISCaM). This series of lectures…

The Euro-BioImaging SAB members and Directorate at EMBL Heidelberg, October 2024. Photo by Kinga Lubowiecka, EMBL/Photolab. 

October 22, 2024

Meeting with our SAB in Heidelberg

The Euro-BioImaging Hub team was delighted to meet in person with our Scientific Advisory Board (SAB) at EMBL Heidelberg October 8-9. The Euro-BioImaging Scientific…

Illuminate_hero

October 21, 2024

ILLUMINATE brings together private-public partners to advance novel theranostics-based cancer treatments

Euro-BioImaging is thrilled to be part of ILLUMINATE (Increasing Lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness), a pioneering 54-month public-private partnership…